| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 760-78-1 | DL-正纈氨酸; DL-2-氨基正戊酸 | DL-NoRVAline; DL-2-Aminovaleric acid; DL-2-Aminovaleric acid; (+/-)-2-Aminopentanoic acid | ![]() | C5H11NO2 | 詳情 | 供應(yīng)商 |
| 2013-12-9 | D-正纈氨酸; R-2-氨基戊酸 | D(-)-NoRVAline; D(-)-2-Aminovaleric acid | ![]() | C5H11NO2 | 詳情 | 供應(yīng)商 |
| 6600-40-4 | L-正纈氨酸; L-2-氨基戊酸 | NoRVAline; L-NoRVAline; L(+)-NoRVAline; L(+)-2-Aminovaleric acid | ![]() | C5H11NO2 | 詳情 | 供應(yīng)商 |
| 40918-51-2 | L-正纈氨酸乙酯鹽酸鹽 | L-NoRVAline ethyl ester hydrochloride; L-NoRVAline,ethyl ester, hydrochloride (9CI) | ![]() | C7H15NO2.HCl;C7H16ClNO2 | 詳情 | 供應(yīng)商 |
| 88426-33-9 | 布帕伐醌; 2-[(4-叔丁基環(huán)己基)甲基]-3-羥基-1,4-萘二酮 | BupaRVAquone; 2-[[4-(1,1-Dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione | ![]() | C21H26O3 | 詳情 | 供應(yīng)商 |
| 110862-48-1 | 阿伐他汀; 阿托伐他汀; (3S,5S)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲;)-5-異丙基吡咯-1-基]-3,5-二羥基? | AtoRVAstatin; (3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid | ![]() | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 119483-47-5 | L-正纈氨酸叔丁酯鹽酸鹽 | L-NoRVAline tert-butyl ester hydrochloride; L-NoRVAline 1,1-dimethylethyl ester hydrochloride | ![]() | C9H20ClNO2 | 詳情 | 供應(yīng)商 |
| 125995-03-1 | 阿托伐他汀內(nèi)酯; (4R,6R)-6-{2-[2-(4-氟苯基)-5-異丙基-3-苯基-4-(苯基氨基甲;)吡咯-1-基]乙基}-4-羥基四 | AtoRVAstatin lactone; (4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one | ![]() | C33H33FN2O4 | 詳情 | 供應(yīng)商 |
| 134523-00-5 | 阿伐他汀; 阿托伐他汀; (3R,5R)-7-[2-(4-氟苯基)-3-苯基-4-(苯基氨基甲;)-5-異丙基-吡咯-1-基]-3,5-二羥基 | AtoRVAstatin; (3R,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-yl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid | ![]() | C33H35FN2O5 | 詳情 | 供應(yīng)商 |
| 134523-03-8 | 阿托伐他汀鈣; 7-[2-(4-氟苯基)-3-苯基-4-(苯胺基甲;)-5-(2-丙基)吡咯-1-基]-3,5-二羥基庚酸鈣 | AtoRVAstatin calcium; Lipitor; [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt | ![]() | (C33H34FN2O5)2.Ca;C66H68CaF2N4O10 | 詳情 | 供應(yīng)商 |
| 648904-28-3 | 巴維昔單抗 | Bavituximab; TaRVAcin | 無 | 詳情 | 供應(yīng)商 | |
| 2051-53-8 | 2-甲基-5-異丙基苯胺 | Benzenamine,2-methyl-5-(1-methylethyl)-; CaRVAcrylamine(6CI,7CI,8CI); 2-Amino-p-cymene; 2-Cymidine; 2-Methyl-5-isopropylaniline; 3-Isopropyl-6-methylphenylamine; 5-Isopropyl-2-methylaniline; 5-Isopropyl-2-methylphenylamine; 5-Isopropyl-o-toluidine; 6-Methyl-3-isopropylaniline; NSC 4021; p-Cymen-2-amine | ![]() | C10H15N | 詳情 | 供應(yīng)商 |
| 6950-94-3 | Benzenamine,N,2-dimethyl-5-(1-methylethyl)-; CaRVAcrylamine,N-methyl- (4CI); NSC 65643 | ![]() | C11H17N | 詳情 | 供應(yīng)商 | |
| 2438-53-1 | Benzenaminium,N,N,N,2-tetramethyl-5-(1-methylethyl)-4-[(1-piperidinylcarbonyl)oxy]-, chloride(1:1); (5-HydroxycaRVAcryl)trimethylammoniumchloride, 1-piperidinecarboxylate (6CI); Ammonium,(5-hydroxycaRVAcryl)trimethyl-, chloride, 1-piperidinecarboxylate (8CI); Benzenaminium,N,N,N,2-tetramethyl-5-(1-methylethyl)-4-[(1-piperidinylcarbonyl)oxy]-, chloride(9CI); (4-Hydroxy-5-isopropyl-2-methylphenyl)trimethylammonium chloride1-piperidinecarboxylate; 2-Isopropyl-4-dimethylamino-5-methylphenyl1-piperidinecarboxylate methochloride; 2-Isopropyl-4-dimethylamino-5-methylphenyl-1-piperidinecarboxylate methylchloride; 2'-Isopropyl-4'-(trimethylammonium chloride)-5'-methylphenylpiperidine-1-carboxylate; Amo 1618; [2-Isopropyl-4-(trimethylammoniumchloride)-5-methylphenyl]-1-piperidinecarboxylate; [5-Isopropyl-2-methyl-4-(piperidinocarbonyloxy)phenyl]trimethylammoniumchloride | ![]() | C32H54ClN3O4 | 詳情 | 供應(yīng)商 | |
| 20347-56-2 | Benzenaminium,N,N,N,2-tetramethyl-4-[[(methylamino)carbonyl]oxy]-5-(1-methylethyl)-, iodide(1:1); Ammonium,(5-hydroxycaRVAcryl)trimethyl-, iodide, methylcarbamate (8CI); Benzenaminium,N,N,N,2-tetramethyl-4-[[(methylamino)carbonyl]oxy]-5-(1-methylethyl)-, iodide(9CI) | ![]() | C28H48IN3O4 | 詳情 | 供應(yīng)商 | |
| 63981-86-2 | Benzenaminium,4-[[(dimethylamino)carbonyl]oxy]-N,N,N,2-tetramethyl-5-(1-methylethyl)-, iodide(1:1); (5-HydroxycaRVAcryl)trimethylammoniumiodide, dimethylcarbamate (6CI); Ammonium, (5-hydroxycaRVAcryl)trimethyl-,iodide, dimethylcarbamate (4CI); Benzenaminium,4-[[(dimethylamino)carbonyl]oxy]-N,N,N,2-tetramethyl-5-(1-methylethyl)-, iodide(9CI) | ![]() | C29H50IN3O4 | 詳情 | 供應(yīng)商 | |
| 83880-23-3 | Benzenamine,4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-; CaRVAcrylamine,5-(2-dimethylaminoethoxy)- (6CI); 2-(4-Amino-2-isopropyl-5-methylphenoxy)-N,N-dimethylethylamine | ![]() | C14H24N2O | 詳情 | 供應(yīng)商 | |
| 74436-00-3 | Cyclosporin G (9CI); CyclosporinA, 7-L-noRVAline-; 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane,cyclic peptide deriv.; 7-L-NoRVAline cyclosporin A; Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-noRVAlyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl]; Cyclo[[(2S,3R,4R,6E)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-noRVAlyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl]; Cyclosporine G; Geclosporin; OG 37-325; SDZ 37-325 | ![]() | C63H113N11O12 | 詳情 | 供應(yīng)商 | |
| 108027-48-1 | Cyclosporin Y (9CI); CyclosporinA, 7-L-noRVAline-11-L-leucine-; 1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptidederiv.; Cyclo[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl-L-noRVAlyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-L-leucyl] | ![]() | C62H111N11O12 | 詳情 | 供應(yīng)商 | |
| 56072-96-9 | Cyclo[2,3-didehydroalanyl-L-alanyl-(2S)-2-hydroxy-4-methylpentanoyl-5-phenyl-L-noRVAlyl](9CI); L-Alanine,N-[2,3-didehydro-N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-5-phenyl-L-noRVAlyl]alanyl]-,k-lactone, (S)-; 1-Oxa-4,7,10-triazacyclododecane, cyclic peptide deriv.; AM toxin II; Cyclic(2,3-didehydroalanyl-L-alanyl-L-a-hydroxyisovaleryl-5-phenyl-L-noRVAlyl); Toxin II(Alternaria mali) | ![]() | C22H29N3O5 | 詳情 | 供應(yīng)商 | |